The importance of reporting patient recruitment details in phase III trials
- PMID: 16484692
- DOI: 10.1200/JCO.2005.02.6005
The importance of reporting patient recruitment details in phase III trials
Comment in
-
Increasing trial generalizability.J Clin Oncol. 2006 Feb 20;24(6):846-7. doi: 10.1200/JCO.2005.04.5120. J Clin Oncol. 2006. PMID: 16484693 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
